Investigational Site Number :2460001

Helsinki 00029 HUS

2 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Heart Failure, Lung Transplant Rejection, Plasma Cell Myeloma, T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction — Recruiting now
• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS) — Running, not enrolling
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early
• Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia — Stopped early